Panacea Biotec has informed that pursuant to the provisions of Regulation 40(10) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company enclosing the certified copy of certificate from R & D, Company Secretaries, for the half-year ended September 30, 2019, confirming that all the transfers of shares have been completed within the stipulated time.
The above information is a part of company’s filings submitted to BSE.